Stay updated on Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-07T01:18:09.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.4%
    Check dated 2025-04-30T00:15:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the addition of a new version identifier and the involvement of the National Cancer Institute as a collaborator. However, critical details regarding the study's objectives and treatment protocols have been removed.
    Difference
    43%
    Check dated 2025-04-22T18:13:57.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-15T14:17:57.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.
    Difference
    0.3%
    Check dated 2025-04-08T09:42:09.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T07:54:00.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.